InsidersTradesSigma
Follow the 2cureX AB stock price and the full insider trade history of the company, a publicly traded company based in Finland. Shares trade on the FI market, under the oversight of FIN-FSA. Operating in the Health Care sector, 2cureX AB has published 3 reports. Market capitalisation: €43.4m. The latest transaction was disclosed on 28 April 2026 (Purchase). Among the most active insiders: Juergen Kupper. All data is free.
3
Insider Decl.
n/a
Thresholds
€349,377
1 ops.
Buy Volume
€20,637
1 ops.
Sell Volume
28Σ signal
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 28 April 2026
Declarations3 total
3,460,134 shares@ €0.1010.64% mcap100.0% of flowAktieISIN SE0010468124FI:A003X897-1
10,600 shares@ SEK 19.75100.0% of flowAktieISIN SE0010468124FI:A001P631-1
31,800 shares0WarrantFI:A001P350-1
3 of 3 declarations
Acerca de 2cureX AB
2cureX AB es una empresa enfocada en el desarrollo de soluciones de diagnóstico para el tratamiento del cáncer. Opera en el sector de la salud y farmacéutico, cotizada en el mercado XSTO.